Diffuse large B cell lymphoma: how can we cure more patients in 2012?
- PMID: 22409822
- DOI: 10.1016/j.beha.2012.01.008
Diffuse large B cell lymphoma: how can we cure more patients in 2012?
Abstract
Clinically this chapter will focus on 3 important issues critical in the management of diffuse large B cell lymphoma (DLBCL) in 2012: risk stratification, interim PET-CT scanning and the role of high dose therapy and ASCT in the rituximab era for patients with relapsed and primary refractory disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
